The release of the 750mcg teriparatide solution in Australia has seen restricted availability to date. Primarily directed for patients with severe osteoporosis who have not responded to other treatments , access is carefully managed. Current supply quantities are limited, and individuals should verify with their doctor the current specifics on obta